Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

Objective: Obesity-linked type 2 diabetes (T2D) is a worldwide health concern and many novel approaches are being considered for its treatment and subsequent prevention of serious comorbidities. Co-administration of glucagon like peptide 1 (GLP-1) and peptide YY3-36 (PYY3-36) renders a synergistic d...

Full description

Saved in:
Bibliographic Details
Main Authors: Brandon B. Boland (Author), Rhianna C. Laker (Author), Siobhan O'Brien (Author), Sadichha Sitaula (Author), Isabelle Sermadiras (Author), Jens Christian Nielsen (Author), Pernille Barkholt (Author), Urmas Roostalu (Author), Jacob Hecksher-Sørensen (Author), Sara Rubek Sejthen (Author), Ditte Dencker Thorbek (Author), Arthur Suckow (Author), Nicole Burmeister (Author), Stephanie Oldham (Author), Sarah Will (Author), Victor G. Howard (Author), Benji M. Gill (Author), Philip Newton (Author), Jacqueline Naylor (Author), David C. Hornigold (Author), Jotham Austin (Author), Louise Lantier (Author), Owen P. McGuinness (Author), James L. Trevaskis (Author), Joseph S. Grimsby (Author), Christopher J. Rhodes (Author)
Format: Book
Published: Elsevier, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available